SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Martin Luther

PatientMartin Luther
Date of birth1982-11-19
IdentifiersMRN HR-RE004-SYN; SSN (made up) 000-04-3892
Document date2026-09-22
AuthorOttilie Brandt-Mensah, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-week review of Ménière disease, depression and the passed stone. [S]

History of Present Illness

Professor Luther returns six weeks after the consultation. He has had one attack since then, of about two hours, ten days before his preventive visit, and none in the three weeks since. He keeps sodium down at home and has cut coffee to a cup a day. Between attacks he feels slightly unsteady when he turns quickly or walks in the dark. The MRI was done last week. The stone he passed nine days after his sick visit has been analyzed. He has taken hydrochlorothiazide and sertraline 50 mg daily; the loose stools on starting sertraline have settled. He has attended five therapy sessions and has begun to plan small pleasant activities each day. His sleep is better, and he has no thoughts of harming himself. [S]

ElementDetail
AttacksOne two-hour attack in six weeks; none in the last three weeks
BalanceSlight unsteadiness on quick turns and in the dark
MedicinesHydrochlorothiazide 25 mg; sertraline 50 mg for five weeks
TherapyFive CBT sessions
SafetyNo suicidal ideation

Review of Systems

SystemResultFinding
Ears, nose, mouth, and throatPositiveTinnitus quieter; fullness only before the last attack
NeurologicalPositiveMild unsteadiness on quick turns; one headache without dizziness
GenitourinaryNegativeNo flank pain or blood in the urine since the stone passed
MusculoskeletalNegativeNo joint pain or swelling
PsychiatricPositiveMood better; sleep seven hours; PHQ-9 10

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Meclizine 25 mg tablet, one by mouth up to every 8 hours during a severe vertigo attack only, for no more than 3 days at a timeevery 8 hours as needed during a severe attack, at most 3 days at a timeOral route2026-07-28activeS
Naproxen 500 mg tablet, one by mouth twice daily with food for up to 7 days for stone paintwice daily with food for up to 7 daysOral route2026-08-25 to 2026-09-01completedS
Tamsulosin 0.4 mg capsule, one by mouth daily for up to 4 weeks or until the stone passesonce daily until the stone passesOral route2026-08-25 to 2026-09-03completedS
Hydrochlorothiazide 25 mg tablet, one by mouth each morningonce daily in the morningOral route2026-08-11activeS
Sertraline 25 mg tablet, one by mouth each morning for one weekonce daily in the morningOral route2026-08-11 to 2026-08-18completedS
Sertraline 50 mg tablet, one by mouth each morningonce daily in the morningOral route2026-08-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-22Body height175cmS
2026-09-22Body weight85.1kgS
2026-09-22Body mass index (BMI) [Ratio]27.8kg/m2S
2026-09-22Systolic blood pressure122mm[Hg]S
2026-09-22Diastolic blood pressure78mm[Hg]S
2026-09-22Heart rate72/minS
2026-09-22Respiratory rate14/minS
2026-09-22Body temperature36.7CelS
2026-09-22Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-22Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
2026-09-22Potassium [Moles/volume] in Serum or Plasma3.7mmol/L3.5-5.1 mmol/LNormalS
2026-09-22Creatinine [Mass/volume] in Serum or Plasma1mg/dL0.74-1.35 mg/dLNormalS
2026-09-22Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
2026-09-22Calcium [Mass/volume] in Serum or Plasma10mg/dL8.6-10.3 mg/dLNormalS
2026-09-22Urate [Mass/volume] in Serum or Plasma7.4mg/dL3.7-8 mg/dLNormalS
2026-09-22Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M96mL/min/{1.73_m2}60 or moreNormalS
2026-09-22Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]10{score}S

Physical Exam

Vital signs recorded on 2026-09-22; see the Vital Signs section. [S]

SystemFinding
GeneralBlood pressure 122/78, pulse 72; weight 85.1 kg
NeurologicalNo nystagmus; head impulse test normal; tandem gait slightly unsteady; Romberg steady on a firm surface, sways on foam with eyes closed
AbdomenNo costovertebral angle tenderness
PsychiatricBrighter, reactive affect; no suicidal ideation

Problems

ProblemClinical statusVerificationCodeProvenance
Recurrent attacks of spinning vertigo for about three months, the worst twelve days ago, lasting hours, with roaring tinnitus, fullness and muffled hearing in the left ear and nausea, the tinnitus persisting between attacks; with low mood, poor sleep and loss of interest; cause not established at intake: an inner-ear disorder suspected, with vestibular migraine, vestibular schwannoma and posterior circulation stroke to be excluded and depression to be assessed; otology consultation requestedresolvedconfirmed R42S — Synthetic presenting problem anchored to his documented attacks of April and July 1527; superseded by the diagnoses at the second visit.
Ménière disease of the left ear, definite (AAO-HNS 2020 and Bárány Society criteria), with low-frequency sensorineural hearing loss and persistent tinnitus in the left ear; vestibular migraine considered and judged unlikely as the main cause; vestibular schwannoma excluded by MRIactiveconfirmed H81.02S — Synthetic modern diagnosis made at the otology consultation, linked to his documented attacks and to the retrospective diagnosis of Ménière disease (R).
Major depressive disorder, recurrent, moderate (DSM-5-TR), with low mood, poor sleep, loss of interest, guilt and fatigue for about two months, after earlier periods of spiritual crisis and low mood; no suicidal ideationactiveconfirmed F33.1S — Synthetic modern diagnosis linked to his documented Anfechtungen and low periods; not a claim that he was so diagnosed; the retrospective psychiatric readings are disputed (R).
Urinary stone disease: one stone passed spontaneously last year after severe pain; stone type and metabolic risk not yet known at intakeactiveconfirmed Z87.442S — Synthetic modern problem anchored to his documented first stone in 1526.
Right distal ureteral stone, 5 mm, at the ureterovesical junction, with mild right hydronephrosis and renal colic; no infection; kidney function normal; managed with naproxen and tamsulosin; passed nine days later; resolvedresolvedconfirmed N20.1S — Synthetic acute problem anchored to his documented recurrent stones; this episode is not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyVertigo attack diary: number, duration, hearing, tinnitus, fullness, headacheEvery visitCompleted todayOne two-hour attack in six weeks, none in three weeks; one headache without vertigo; Dizziness Handicap Inventory 36 (Dizziness Handicap Inventory in the notes; no LOINC code used)
ImagingMRI of the internal auditory canals with gadoliniumOnce, to exclude a retrocochlear lesion with asymmetric hearing lossCompleted todayNo vestibular schwannoma or other lesion
LaboratorySodium, potassium, creatinine and calcium on a thiazide with an SSRITwo to four weeks after starting, then every three to six monthsCompleted todaySodium 137 and potassium 3.9 mmol/L two weeks after starting, drawn at the sick visit; today sodium 136, potassium 3.7 mmol/L, creatinine 1.0 mg/dL, calcium 10.0 mg/dL, glucose 92 mg/dL
LaboratoryUric acid on a thiazide in a stone formerBaseline, then with the 24-hour urineCompleted today7.4 mg/dL, from 6.9; no gout
ExaminationBalance between attacksEvery visitCompleted todayMild unsteadiness on tandem gait and on foam with eyes closed
ReferralVestibular rehabilitation for chronic imbalanceWhen imbalance persists between attacksReferredReferred to a vestibular physical therapist today
Medication safetyVestibular suppressant useEvery visitCompleted todayOne meclizine dose in six weeks
Self-managementSodium, caffeine and alcohol limitsEvery visitCompleted todaySalt cut at home, not when dining out; one coffee a day; beer unchanged
ImagingRenal ultrasound after stone passageOnce after passageCompleted todayNo hydronephrosis and no remaining stones
LaboratoryStone analysisEach stone retrievedCompleted todayCalcium oxalate monohydrate 80 percent, calcium phosphate 20 percent (reported in text; no observation stored)
Laboratory24-hour urine for a recurrent stone formerAbout six weeks after the stone passed; then within six months of starting treatmentOrderedKit given; to be collected before the next visit
SurveyPHQ-9At least monthly during acute treatmentCompleted today10, from 15 at intake
SurveySuicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9)Every visitCompleted todayNo suicidal ideation, intent or plan; PHQ-9 item 9 scored 0. Safety plan reviewed
Medication safetySSRI tolerability check two weeks after starting2 weeks after starting and after each dose changeCompleted todayDone at the sick visit two weeks after starting and at the preventive visit: loose stools for a few days only; no activation
Self-managementPsychotherapy attendanceWeeklyCompleted todayFive CBT sessions attended

Goal progress:

Guideline basis: Clinical Practice Guideline: Ménière's Disease (2020); Medical Management of Kidney Stones: AUA Guideline (2014); Surgical Management of Stones: American Urological Association/Endourological Society Guideline, Part I (2016); Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)

Follow-up: 24-hour urine before the next visit. Review in five weeks with a repeat audiogram. Next scheduled visit 2026-10-27: thirteen-week review: attacks, repeat audiogram, mood, and the 24-hour urine for stone prevention. [S]